• sense clinically
  • think mechanistically
  • act interdisciplinarily
  • treat innovatively

Dr. rer. nat. Thomas Kammertöns

Institute for Immunology
Charité - Universitätsmedizin Berlin
13125 Berlin
E-Mail: tkamm@ mdc-berlin.de

University Education

  • 1989-1996 Biology und North American Studies, FU Berlin
  • 1994-1995 Fulbright scholarship, Vanderbilt University, USA
  • 1996-2001 Ph.D., MDC

Professional Experience (selection)

  • 2001-2004 Staff scientist at the MDC
  • Since 2004 Staff scientist at the Institute of Immunology, Charité

Research Fields

  • i)    Tumor immunology
  • ii)   Immunology
  • iii)  Gene therapy

Most important Awards, Grants or Scientific Achievements

  • PI Research Training Group SFB/TRR 36, PI Project B1 SFB/TRR 36

Selected References

  • Briesemeister, D., Sommermeyer, D., Loddenkemper, C., Loew, R., Uckert, W., Blankenstein, T., Kammertoens, T. (2011). Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis. Int J Cancer 128, 371.
  • Shalapour, S., Eckert, C., Seeger, K., Pfau, M., Prada, J., Henze, G., Blankenstein, T., Kammertoens, T. (2010). Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia. J Mol Med 88, 249.
  • Kammertoens, T., Willebrand, R., Erdmann, B., Li, L., Li, Y., Engels, B., Uckert, W., Blankenstein, T. (2005). CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells. Cancer Res 65, 2560.